Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00351624 · ClinicalTrials.gov registry record · Phase 3
Effects of Docosahexaenoic Acid (DHA) on Cognitive Function in Children 4 Years of Age
A Phase 3 study, sponsored by dsm-firmenich Switzerland.
- Completed
- Registry status
- Phase 3
- Development phase
- 216
- Enrollment target
NCT00351624: Completed Phase 3 study, sponsored by dsm-firmenich Switzerland.
NCT00351624 is a Phase 3 study that has completed, run by dsm-firmenich Switzerland. The registered enrollment target is 216 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (72% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00351624, a Phase 3 study, has completed, sponsored by dsm-firmenich Switzerland.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 216 participants
- Enrollment target
Study Summary
The primary objective of this study is to determine whether a 4-month period of supplementation with 400 mg/day of docosahexaenoic acid (DHA) provided from chewable softgel capsules containing bubblegum flavored microalgal oil (DHASCO-S) versus placebo improves one or more cognitive measures of attention, memory, processing speed, and error rate in healthy children 4 years of age. The secondary objectives are to measure the safety and tolerability of the DHA dose administered and to measure blood DHA levels before and after supplementation.
Interventions
- BEHAVIORAL placebo
- BEHAVIORAL DHA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 216 participants |
| Start Date | 2006-05 |
| Est. Completion | 2007-09 |
| Phase | Phase 3 |
What the finished NCT00351624 record still lists
NCT00351624 is an interventional study that assigns participants to a tested intervention. The registered 216 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (72% lower).
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00351624 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00351624 about?
NCT00351624 is a clinical study titled "Effects of Docosahexaenoic Acid (DHA) on Cognitive Function in Children 4 Years of Age". The primary objective of this study is to determine whether a 4-month period of supplementation with 400 mg/day of docosahexaenoic acid (DHA) provided from chewable softgel capsules containing bubblegum flavored microalgal oil (DHASCO-S) versus placebo improves one or more cognitive measures of atte...
What is the current status of trial NCT00351624?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 216 participants. The study started on 2006-05. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00351624?
The interventions under investigation include: placebo (BEHAVIORAL), DHA (BEHAVIORAL).
Who is sponsoring clinical trial NCT00351624?
This trial is sponsored by dsm-firmenich Switzerland, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00351624's enrollment target sits among peer trials
216 1332nd of 2000 higher than 667 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02609685 · 216 participants · NA
Active Surveillance of Papillary Thyroid Microcarcinoma
- NCT04994873 · 216 participants · NA
Skills to Enhance Positivity in Suicidal Youth
- NCT05264779 · 216 participants · NA
The Periviable GOALS Decision Support Tool
- NCT05434130 · 216 participants · Phase 2
Modulating Exercise Dosage to Improve Concussion Recovery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia